Science Sparks @ ACTREC
Publications
- 1. Mangale P, Agrawal A, Choudhury S, Prakash G, Murthy V, Joshi A, Menon S, Pal M, Rangarajan V (2026). 68Ga prostate-specific membrane antigen PET/computed tomography in benign and malignant prostatic lesions: a study of maximum standardized uptake value and uptake patterns with clinicopathological correlation. Nuclear Medicine Communications.
- 2. Tembhare P, Sehgal K, Bommannan K, Rahman K, Jain S, Dayal N, Ghogale S, Jayaram A, Sachdeva MUS, Gupta R, Subramanian PG, Manivannan P, Galande M, Mundada M, Rath A, Datari P, Rajpal S, Chatterjee G, Deshpande N, Kathirvel K, Singh K, Bagal B, Punatar S, Pandrowala A, Dhamne C, Handoo A, Julio-Javier, Popov A, Salem D, Westerman D, Orfao A (2026). Consensus recommendations for technical standardization of flow cytometric measurable residual disease assessment in B-cell acute lymphoblastic leukemia: A report from The Cytometry Society, India. Cytometry Part B Clinical Cytometry.
- 3. Kumar G, Kant R, Joshi D, Singh K, Cherian JJ, Rajan KRV, Malik S, Das S, Roy SP, Satam V, Guria RT, Kumar D, Majhee L, Kumar A, Krishnamurthy MN, Sharma LK, Chaudhary A, Scandale I, Specht S, Sahu S, Meher M, Mohapatra SG, Mukherjee A, Gupta TM (2026). A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms. Infectious Diseases and Therapy.
- 4. Tambe M, Das D, Firfire A, Rajak J, D'Silva SZ (2026). Identification of the Novel HLA-C*04:03:01:07 Allele in a North Indian Individual From a Yadav Family. HLA.108(2):e70900
- 5. Karale B, Tambe M, Rajak J, D'Silva SZ. Identification of the Novel HLA-A*33:03:01:32 and HLA-C*04:01:01:205 Alleles in Two Individuals From India. HLA. 2026 108(2):e70903.
- 6. Maniar J, Gandhi KA, Gupta S (2026). Correspondence: Beyond phenotypic observations: Elucidating the molecular drivers of hypoxia-reoxygenation-induced aggressiveness in breast cancer. Molecular Biology Reports. 53(1):1365.

Interesting Reads
Upcoming Events
August 21-23, 2026,
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
September 3-5, 2026,
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai
October 26-29, 2026
At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai.
Do You Know?
In 1996, FDA approved anastrozole (Arimidex) as a treatment for breast cancer. This drug blocks the production of estrogen.

Cancer News
EurekAlert, 06/08/2026
These findings identify the causative genes behind IBMFS and germline predisposition to MDS, and provide new insights into how defects in SLF2 and SMC5 promote hematopoietic stem cell aging, results that also give researchers clues for identifying the genetic causes...
News-Medical, 05/08/2026
To make the discovery, the researchers developed the first mouse models capable of specifically labelling or removing activated dendritic cells. This allowed them to determine exactly how activated dendritic cells contribute to anti-cancer immunity.
Sciencedaily, 04/08/2026
Chemotherapy-surviving ovarian cancer cells may release fructose to help neighboring tumor cells loosen, escape, and spread. The discovery suggests that sugary diets and cholesterol-lowering drugs could influence cancer progression, though the effects have not yet been confirmed in patients...
© 2026 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)



